CNNM2 c.*6211C>T

Variant ID: 10-104843148-C-T

NM_017649.4(CNNM2):c.*6211C>T

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives.

Pharmaceutics
Pinto-Merino, Álvaro Á; Labrador, Jorge J; Zubiaur, Pablo P; Alcaraz, Raquel R; Herrero, María José MJ; Montesinos, Pau P; Abad-Santos, Francisco F; Saiz-Rodríguez, Miriam M
Publication Date: 2022-03-03

Variant appearance in text: rs11191547
PubMed Link: 35335935
Variant Present in the following documents:
  • Main text
  • pharmaceutics-14-00559.pdf
View BVdb publication page



Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal
Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL
Publication Date: 2019-04

Variant appearance in text: rs11191547
PubMed Link: 30214008
Variant Present in the following documents:
  • NIHMS1503453-supplement-3.xlsx, sheet 1
View BVdb publication page



Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia.

Journal Of Human Genetics
Yee, Sook Wah SW; Mefford, Joel A JA; Singh, Natasha N; Percival, Mary-Elizabeth ME; Stecula, Adrian A; Yang, Kuo K; Witte, John S JS; Takahashi, Atsushi A; Kubo, Michiaki M; Matsuda, Koichi K; Giacomini, Kathleen M KM; Andreadis, Charalambos C
Publication Date: 2013-06

Variant appearance in text: rs11191547
PubMed Link: 23677058
Variant Present in the following documents:
  • Main text
View BVdb publication page